KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Change in Accured Expenses: 2009-2024

Historic Change in Accured Expenses for Chemed (CHE) over the last 16 years, with FY2024 value amounting to $22.7 million.

  • Chemed's Change in Accured Expenses rose 8464.48% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year decrease of 7693.81%. This contributed to the annual value of $22.7 million for FY2024, which is 7769.88% up from last year.
  • Chemed's Change in Accured Expenses amounted to $22.7 million in FY2024, which was up 7769.88% from $12.8 million recorded in FY2023.
  • Over the past 5 years, Chemed's Change in Accured Expenses peaked at $22.7 million during FY2024, and registered a low of -$3.4 million during FY2022.
  • Its 5-year average for Change in Accured Expenses is $11.3 million, with a median of $12.3 million in 2020.
  • As far as peak fluctuations go, Chemed's Change in Accured Expenses crashed by 12774.56% in 2022, and later surged by 48214.93% in 2023.
  • Over the past 5 years, Chemed's Change in Accured Expenses (Annual) stood at $12.3 million in 2020, then fell by 2.02% to $12.1 million in 2021, then crashed by 127.75% to -$3.4 million in 2022, then surged by 482.15% to $12.8 million in 2023, then soared by 77.7% to $22.7 million in 2024.
  • Its Change in Accured Expenses stands at $22.7 million for FY2024, versus $12.8 million for FY2023 and -$3.4 million for FY2022.